SPDR S&P Biotech ETF $XBI Stock Acquired by Pekin Hardy Strauss Inc.

Pekin Hardy Strauss Inc. increased its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 52.2% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 10,804 shares of the exchange traded fund’s stock after buying an additional 3,704 shares during the quarter. Pekin Hardy Strauss Inc.’s holdings in SPDR S&P Biotech ETF were worth $1,704,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also recently bought and sold shares of the company. Axiom Investment Management LLC purchased a new stake in SPDR S&P Biotech ETF in the 1st quarter worth about $26,000. Angeles Wealth Management LLC purchased a new position in SPDR S&P Biotech ETF during the 2nd quarter valued at about $28,000. Root Financial Partners LLC purchased a new position in SPDR S&P Biotech ETF during the 3rd quarter valued at about $31,000. Signature Equity Partners LLC grew its stake in SPDR S&P Biotech ETF by 1,285.7% during the 3rd quarter. Signature Equity Partners LLC now owns 194 shares of the exchange traded fund’s stock valued at $31,000 after acquiring an additional 180 shares in the last quarter. Finally, Morling Financial Advisors LLC acquired a new position in shares of SPDR S&P Biotech ETF in the 2nd quarter valued at about $36,000.

SPDR S&P Biotech ETF Stock Up 2.6%

Shares of XBI traded up $3.81 during trading hours on Friday, reaching $152.21. The company’s stock had a trading volume of 10,549,785 shares, compared to its average volume of 9,198,628. The company has a 50 day moving average of $155.22 and a two-hundred day moving average of $142.29. The firm has a market cap of $10.41 billion, a price-to-earnings ratio of 11.47 and a beta of 0.87. SPDR S&P Biotech ETF has a 1-year low of $106.30 and a 1-year high of $169.89.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.